We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$273M
AUM Growth
+$58.5M
Cap. Flow
+$33.4M
Cap. Flow %
12.22%
Top 10 Hldgs %
31.23%
Holding
76
New
17
Increased
24
Reduced
16
Closed
9

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$8.93M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$6.98M
3
GILD icon
Gilead Sciences
GILD
+$5.99M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.38M
5
SYK icon
Stryker
SYK
+$4.12M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.73M
2
ZBH icon
Zimmer Biomet
ZBH
+$4.88M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.21M
4
THC icon
Tenet Healthcare
THC
+$3.98M
5
AZN icon
AstraZeneca
AZN
+$3.89M

Sector Composition

Rank Sector Weight
1 Healthcare 87.53%
2 Financials 2.5%
3 Energy 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
1
DELISTED
Alexion Pharmaceuticals
ALXN
$13.4M 4.9%
110,000
+60,000
+120% +$6.98M
UNH icon
2
UnitedHealth
UNH
$389B
$9.73M 3.56%
52,500
+7,500
+17% +$1.32M
JNJ icon
3
Johnson & Johnson
JNJ
$643B
$9.26M 3.39%
+70,000
New +$8.93M
HUM icon
4
Humana
HUM
$46.7B
$8.42M 3.08%
35,000
– –
CELG
5
DELISTED
Celgene Corp
CELG
$7.79M 2.85%
60,000
+12,500
+26% +$1.53M
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$12B
$7.72M 2.83%
85,000
+30,000
+55% +$2.73M
INCY icon
7
Incyte
INCY
$26B
$7.55M 2.77%
60,000
+10,000
+20% +$1.27M
ELV icon
8
Elevance Health
ELV
$83.7B
$7.53M 2.75%
40,000
-3,795
-9% -$682K
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$124B
$7.09M 2.59%
55,000
+5,000
+10% +$602K
AET
10
DELISTED
Aetna Inc
AET
$6.83M 2.5%
45,000
-9,900
-18% -$1.4M
CI icon
11
Cigna
CI
$79.6B
$6.7M 2.45%
40,000
-8,504
-18% -$1.37M
BSX icon
12
Boston Scientific
BSX
$68.5B
$6.65M 2.44%
240,000
+40,000
+20% +$1.06M
CNC icon
13
Centene
CNC
$31.6B
$6.39M 2.34%
160,000
+30,000
+23% +$1.13M
GILD icon
14
Gilead Sciences
GILD
$167B
$6.37M 2.33%
+90,000
New +$5.99M
WCG
15
DELISTED
Wellcare Health Plans, Inc.
WCG
$6.29M 2.3%
35,000
-20,000
-36% -$3.31M
BAX icon
16
Baxter International
BAX
$12.6B
$6.05M 2.22%
100,000
-10,000
-9% -$568K
MOH icon
17
Molina Healthcare
MOH
$10.5B
$5.71M 2.09%
82,500
+62,500
+313% +$3.84M
RVTY icon
18
Revvity
RVTY
$12.4B
$5.45M 2%
80,000
-10,000
-11% -$621K
BIIB icon
19
Biogen
BIIB
$30.4B
$5.43M 1.99%
20,000
+5,000
+33% +$1.32M
COR icon
20
Cencora
COR
$62.2B
$5.2M 1.9%
55,000
+10,000
+22% +$891K
MCK icon
21
McKesson
MCK
$104B
$4.94M 1.81%
30,000
– –
REGN icon
22
Regeneron Pharmaceuticals
REGN
$72.9B
$4.91M 1.8%
+10,000
New +$4.38M
BDX icon
23
Becton Dickinson
BDX
$45.8B
$4.88M 1.79%
25,625
+5,125
+25% +$936K
ABT icon
24
Abbott
ABT
$187B
$4.86M 1.78%
100,000
– –
MRK icon
25
Merck
MRK
$326B
$4.81M 1.76%
78,600
– –
1
2 3

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
FF
Fairway Financial Casselberry, Florida $132M AUM 13.23% 1-Year Est. Return

Sivik Global Healthcare's Q2 2017 Portfolio in Review

As of Q2 2017, Sivik Global Healthcare held 76 positions worth $273M, up 27% from $215M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sivik Global Healthcare deployed $33.4M of net new capital in Q2 2017, opening 17 new positions and adding to 24 existing holdings. Its largest new stake was Johnson & Johnson: 70,000 shares worth $9.26M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 88% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $3.31M trimmed.

  • Sivik Global Healthcare's largest Q2 2017 buy was Johnson & Johnson: 70,000 shares worth $9.26M.
  • Sivik Global Healthcare added most to Alexion Pharmaceuticals in Q2 2017, an estimated $6.98M increase.
  • Sivik Global Healthcare's biggest Q2 2017 reduction was Wellcare Health Plans, Inc., cutting an estimated $3.31M.
  • Sivik Global Healthcare fully exited Eli Lilly in Q2 2017, selling an estimated $6.73M.
  • Sivik Global Healthcare's ten largest holdings make up 31% of its $273M portfolio in Q2 2017.
  • Sivik Global Healthcare opened 17 new positions and closed 9 in Q2 2017.
  • Sivik Global Healthcare's portfolio value rose 27% quarter-over-quarter to $273M.

Based on Sivik Global Healthcare's 13F filing for Q2 2017, filed 11 Aug 2017.